跳至主要内容
临床试验/TCTR20190607003
TCTR20190607003已完成未知

Fibrinolytic-Associated Urticaria, Angioedema, and Type I Hypersensitivity Reactions from Various Indications

o sponsor0 个研究点目标入组 11 人开始时间: 2019年6月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 89 Years(—)
性别
All

入选标准

  • Medical records, either electronic or paper, were reviewed and collected clinical characteristic including gender, age, body weight, baseline systolic and diastolic blood pressure, co-morbidities, medication prior to admission, history of medication allergy, history of prior streptokinase exposure, indications, dosage and administration, premedication strategy, concomitant medications, echocardiogram, electrocardiogram, computed tomography scan, NIHSS score, vital signs, laboratory data. We especially reviewed the medical records of all cases of suspected urticaria, angioedema, and type I hypersensitivity reactions. The following data were extracted: first and last date of fibrinolytic agent usage, onset of suspected reactions, management and clinical outcomes.

排除标准

  • No exclusion criteria

研究者

发起方
o sponsor

相似试验